Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

SUMMARY OF MEDTECH'S LIQUIDITY CONTRACT WITH ODDO CORPORATE FINANCE



Montpellier, France, January 12, 2016

 


Pursuant to the liquidity contract granted to Oddo Corporate Finance regarding Medtech shares, the following resources were listed in the liquidity account as of December 31, 2015:



  • 14,052 Medtech shares

  • 168,343.29 Euros

As of June 30, 2015, the most recent update, the following resources had been allocated to the liquidity account:



  • 6,360 Medtech shares

  • 368,737.44 Euros













About MEDTECH

Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013 MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the “listed company” category.

In 2015 MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine.
CONTACT MEDTECH

Christophe Sibillin

Chief Financial Officer

Tel : +33 (0)4 67 10 77 40
INVESTORS

Corinne Puissant

Tel : +33 (0)1 53 67 36 77

[email protected]
PRESS

Alexandra Prisa (EU)

Tel. : +33(0)1 53 67 36 90

[email protected]
 

Joanna Zimmerman (US)

Tel : +1 646-536-7006

[email protected]
 

Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité

Full and original press release in PDF:


http://www.actusnews.com/documents_communiques/ACTUS-0-42729-MEDTECH-contrat-de-liquidite-decembre-2015-VUK.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments